ITRM
Iterum Therapeutics plc
NASDAQ · Healthcare · Biotechnology · IE
$0.03
−10.98%Margins
Gross margin
-171.3%
EBITDA margin
-5915.6%
EBIT margin
-5202.8%
Net margin
-6913.1%
FCF margin
-5110.0%
365.3%
Return on equity
-82.9%
Return on assets
-77.0%
Return on invested capital
0.01x
Asset turnover
-$19.9M
Cash from operations
$0.24
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2025